Bevacizumab is also not used in cases of squamous cell cancer, because it leads to bleeding from this type of lung cancer.
2
大部分鳞状细胞癌患者当中没有明确有获益。该药不被批准用于鳞状非小细胞肺癌患者维持治疗。
No benefit was seen among patients with predominantly squamous cell cancer. The drug is not approved for patients with squamous cell non-small cell lung cancer.
3
他们还指出，4种病理类型肺癌中仅发现小细胞癌和鳞状细胞癌的风险降低。
They also noted that, of the 4 histologic subtypes of lung cancer, the risk reduction was only seen for small cell carcinoma and squamous cell carcinoma.
点击反馈